High-fructose corn syrup promotes proinflammatory Macrophage activation via ROS-mediated NF-κB signaling and exacerbates colitis in mice.
Study Design
- Studientyp
- Other
- Population
- None
- Intervention
- High-fructose corn syrup promotes proinflammatory Macrophage activation via ROS-mediated NF-κB signaling and exacerbates colitis in mice. None
- Vergleichsgruppe
- None
- Primärer Endpunkt
- None
- Wirkungsrichtung
- Mixed
- Verzerrungsrisiko
- Unclear
Abstract
The dramatically increasing incidence and prevalence of inflammatory bowel disease (IBD) are reportedly related to a Western diet, which is characterized by high sugar consumption. Dietary simple sugars aggravate IBD in animal models. However, the mechanisms underlying this effect remain unclear. Given that high-fructose corn syrup (HFCS) is a major added sugar in food and beverages, we focus on HFCS and investigated the effects of HFCS on a dextran sulfate sodium (DSS)-induced murine colitis model and in RAW264.7 macrophages. Our data demonstrate that short-term consumption of HFCS aggravates colitis and upregulates the proportion of macrophages in IBD mice but not in healthy mice. We find that HFCS promotes proinflammatory cytokine production through reactive oxygen species (ROS)-mediated nuclear factor-κB (NF-κB) signaling in RAW264.7 macrophages. Furthermore, N-acetylcysteine (NAC), an ROS scavenger, alleviates HFCS-aggravated colitis in mice and inhibits the ROS-mediated NF-κB signaling pathway in RAW264.7 macrophages. Our work unveils the important role of macrophages in HFCS-induced exacerbation of colitis and reveals the mechanism of how HFCS immunologically aggravates IBD.
Zusammenfassung
It is demonstrated that short-term consumption of HFCS aggravates colitis and upregulates the proportion of macrophages in IBD mice but not in healthy mice, and the mechanism of how H FCS immunologically aggravates IBD is revealed.
Used In Evidence Reviews
Similar Papers
Digestion · 2016
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Gut · 1996
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.
Journal of nanobiotechnology · 2022
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy.
Frontiers in endocrinology · 2024
The emerging role of oxidative stress in inflammatory bowel disease.
The British journal of nutrition · 2012
Omega-3 fatty acids and inflammatory bowel diseases - a systematic review.
Helicobacter · 2007